At what enterprise value was HALLMARQ VETERINARY IMAGING acquired in 2026?

You can find the full valuation details of HALLMARQ VETERINARY IMAGING on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 13.4x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of HALLMARQ VETERINARY IMAGING when it was acquired by NORD HOLDING?

The exact EV/EBITDA multiple for HALLMARQ VETERINARY IMAGING is available on mynth capital. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 13.4x. Join our community for free to access full valuation data and industry trends.

When was HALLMARQ VETERINARY IMAGING acquired by NORD HOLDING?

HALLMARQ VETERINARY IMAGING was acquired by NORD HOLDING in 2026.

What was the revenue of HALLMARQ VETERINARY IMAGING at the time of the deal?

The revenue of HALLMARQ VETERINARY IMAGING at the time of the deal is estimated to be in the range of 5M - 25M EUR. Register for free to access the full transaction report and exact valuation multiples.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the HALLMARQ VETERINARY IMAGING acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the HALLMARQ VETERINARY IMAGING deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.fyb.de/en/nord-holding-acquires-british-hallmarq-veterinary-imaging/

← DATABASE

Home Database Healthcare & PharmaHALLMARQ VETERINARY IMAGING

02/2026

HALLMARQ VETERINARY IMAGING

Acquired by

NORD HOLDING

UNITED KINGDOM Life Sciences / Medical Devices / Diagnostic Equipment REV 5M - 25M EUR

HALLMARQ VETERINARY IMAGING acquired by NORD HOLDING

UNITED KINGDOM Life Sciences / Medical Devices / Diagnostic Equipment REV 5M - 25M EUR

Context

NORD Holding have acquired Hallmarq Veterinary Imaging from August Equity to merge it with German-based OR Technology. The transaction establishes a new, globally active imaging technology holding company in the veterinary sector. This is the second acquisition by NORD Holding in this sector in less than a year, following its partnership with OR Technology in 2025. The strategic rationale is to create a "one-stop-shop" for veterinary imaging, combining Hallmarq's specialized MRI/CT expertise with OR Technology’s digital X-ray and ultrasound portfolio. The combined group employs over 200 people across Europe, MEA, and North America. The merger allows for significant cross-selling opportunities and the integration of AI-supported diagnostic tools across a wider range of clinical applications, positioning the group as a global leader in multimodality veterinary diagnostics.

HALLMARQ VETERINARY IMAGING, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Healthcare & Pharma sector (13.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Hallmarq Veterinary Imaging is a global pioneer in species-specific diagnostic imaging for veterinary practices. Its business model focuses on developing advanced MRI and CT solutions tailored specifically for equine and small animal medicine. The company’s value proposition centers on clinical innovation, such as the world’s first upright MRI for horses and helium-free 1.5T MRI systems for small animals, which eliminate the need for specialized cryogen logistics. Strategically, Hallmarq operates a service-heavy model across 28 countries, providing ongoing technical support and software-driven diagnostics (e.g., iNAV motion correction) to referral centers and veterinary hospitals. By focusing on "animal-first" engineering, the firm improves diagnostic accuracy while reducing facility modification costs for veterinary practitioners.

Ent. Value

Equity Value

Multiples Analysis

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2025

2024

Other operations with HALLMARQ VETERINARY IMAGING

REFERENCES

Revenue range: 5M - 25M EUR

Note: Detailed and exact financial metrics (Enterprise Value, Revenue, EBITDA, and precise Multiples) are reserved for Mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: nord holding